表紙:小児向けワクチンの世界市場:将来予測
市場調査レポート
商品コード
664177

小児向けワクチンの世界市場:将来予測

Pediatric Vaccines Market - Global Forecast to 2026

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 189 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.28円
小児向けワクチンの世界市場:将来予測
出版日: 2018年05月31日
発行: Coherent Market Insights
ページ情報: 英文 189 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の小児用ワクチンの市場について分析し、市場の基本構造や背景事情 (関連疾患の概要、規制情報など)、主な市場促進・抑制要因、全体的な市場規模の動向見通し (今後10年間分)、ワクチンの種類別・流通チャネル別・地域別の詳細動向、主要企業のプロファイルと業績、今後の市場の方向性などを調査しております。

第1章 分析目的と前提条件

第2章 市場概略

  • 分析概略
  • エグゼクティブ・サマリー
  • COM (Coherent Opportunity Map:市場機会マップ)

第3章 市場のダイナミクス・規制・動向の分析

  • 市場のダイナミクス
    • 促進要因
    • 抑制要因
    • 市場機会
  • 市場動向
  • 疫学的傾向
  • 近年の主な動き
    • 認知度向上戦略
    • 企業合併・買収 (M&A)
    • 規制シナリオ
    • 新製品の認証/上市
  • PEST分析
  • ポーターのファイブフォース分析

第4章 世界の小児ワクチン市場:ワクチンの種類別

  • イントロダクション
    • 市場シェア分析 (最新値・予測値)
    • 年間成長率の分析 (今後10年間分)
    • 部門別分析
  • 単価ワクチン
    • イントロダクション
    • 市場規模とその予測、年間成長率 (金額ベース、今後11年間分)
  • 多価ワクチン

第5章 世界の小児ワクチン市場:ワクチンの形状別

  • イントロダクション
  • 弱毒生ウイルス
  • 不活化ウイルス
  • サブユニット
  • トキソイド (毒素類)
  • 遺伝子組み換えワクチン
  • 多糖体 (ポリサッカロイド)
  • 結合型ワクチン

第6章 世界の小児ワクチン市場:用途別

  • イントロダクション
  • 感染症向け
  • アレルギー向け

第7章 世界の小児ワクチン市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 小児科クリニック
  • 教育・研究機関
  • その他

第8章 世界の小児ワクチン市場:地域別

  • イントロダクション
  • 北米市場 (米国、カナダ)
    • 市場規模とその予測、ワクチンの種類別 (金額ベース、通算11年間分)
    • 市場規模とその予測、ワクチンの形状別 (金額ベース、通算11年間分)
    • 市場規模とその予測、用途別 (金額ベース、通算11年間分)
    • 市場規模とその予測、国別 (金額ベース、通算11年間分)
  • 欧州市場 (英国、ドイツ、イタリア、スペイン、フランス、ロシアなど)
  • アジア太平洋地域市場 (中国、日本、インド、ASEAN諸国、オーストラリア、韓国など)
  • ラテンアメリカ市場 (ブラジル、メキシコ、アルゼンチンなど)
  • アフリカ市場 (北部アフリカ、中部アフリカ、南アフリカ)
  • 中東市場 (湾岸協力会議 (GCC) 諸国、イスラエルなど)

第9章 競争環境

  • ヒートマップ分析
  • 企業プロファイル
    • GlaxoSmithKline plc
    • Serum Institute of India Pvt. Ltd.
    • Eli Lilly Company
    • AstraZeneca plc
    • Pfizer, Inc.
    • Aventis Pharma Limited
    • Indian Immunologicals Limited
    • Zydus Cadila
    • Panacea Drugs Pvt. Ltd.
    • Sinovac Biotech Ltd.

第10章 付録

目次

Report Description

  • Pediatric vaccines are revolutionizing the healthcare industry by providing protection against the severe illnesses, thereby enabling improved heath and reduced family stress. Moreover, childhood immunization is essential step in maintaining high vaccination levels within the population, which prevents outbreaks such as diphtheria, hepatitis A, hepatitis B, influenza, Haemophilus influenzae type b (Hib), measles, and mumps. Various government healthcare organizations such as the United Nations Children's Fund (UNICEF), American Academy of Pediatrics (AAP), and World Health Organization (WHO) are engaged in initiating various immunization awareness programmes to increase vaccination among the pediatric population.

Market Dynamics

  • The Centers for Disease Control and Prevention (CDC) recommends immunizing children against most of the vaccine preventable disease by the time they are two years old. These resulted in elimination of some of the infectious disease completely in various countries. For instance, Polio and smallpox have been eliminated in the U.S. due to effective vaccination. In March 2014, World Health Organisation (WHO) declared India as polio-free nation.
  • Increasing prevalence of chronic and infectious disease, along with growing awareness regarding childhood immunization among various developed and emerging economies lead to boost the growth of pediatric vaccines market in near future. Furthermore, increasing alliances, partnership, and collaborations among key players to introduce
  • efficient vaccines in the market is expected to drive growth of the market in near future.

Key features of the study:

  • This report provides in-depth analysis of pediatric vaccines and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global pediatric vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Eli Lilly Company, AstraZeneca plc, Pfizer, Inc., Aventis Pharma Limited, Indian Immunologicals Limited, Zydus Cadila, Panacea Drugs Pvt. Ltd., and Sinovac Biotech Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, pediatric vaccine manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

  • Global Pediatric Vaccines Market, By Vaccine Type:
  • Monovalent
  • Multivalent
  • Global Pediatric Vaccines Market, By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
  • Global Pediatric Vaccines Market, By Application:
  • Infectious Disease
  • Allergy
  • Global Pediatric Vaccines Market, By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Global Pediatric Vaccines Market, By Geography:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Europe
    • By Country:
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Russia
  • Rest of Europe
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Rest of Asia Pacific
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Africa
    • By Country:
  • South Africa
  • Central Africa
  • North Africa
    • By Vaccine Type:
  • Monovalent
  • Multivalent
    • By Vaccine Form:
  • Attenuated Live Viruses
  • Inactivated Viruses
  • Subunits
  • Toxoids
  • Recombinant
  • Polysaccharides
  • Conjugates
    • By Application
  • Infectious Disease
  • Allergy
    • By End User:
  • Hospitals
  • Pediatric Clinics
  • Research Organizations
  • Others
  • Company Profiles
  • GlaxoSmithKline plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments
    • Strategies
  • Serum Institute of India Pvt. Ltd.
  • Eli Lilly Company
  • AstraZeneca plc
  • Pfizer, Inc.
  • Aventis Pharma Limited
  • Indian Immunologicals Limited
  • Zydus Cadila
  • Panacea Drugs Pvt. Ltd.
  • Sinovac Biotech Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Vaccine Type
    • Market Snippet By Vaccine Form
    • Market Snippet By Application
    • Market Snippet By End-User
    • Market Snippet By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Market Trends
    • Epidemiology
    • Key Developments
    • Awareness Strategies
    • Merger and Acquisitions
    • Regulatory Scenario
    • New Product Approvals/Launch
    • PEST Analysis
    • Porter's Analysis

4. Global Pediatric Vaccines Market, By Vaccine Type, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Monovalent
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Multivalent
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

5. Global Pediatric Vaccines Market, By Vaccine Form, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Attenuated Live Viruses
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Inactivated Viruses
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Subunits
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Toxoids
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Recombinant
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Polysaccharides
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Conjugates
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

6. Global Pediatric Vaccines Market, By Application, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Infectious Disease
    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
  • Allergy
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

7. Global Pediatric Vaccines Market, By End-User, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Pediatric Clinics
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Academic & Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2016 - 2026, (US$ Million)

8. Global Pediatric Vaccines Market, By Regions, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2017 and 2026 (%)
    • Y-O-Y Growth Analysis, For Regions, 2017 - 2026
  • North America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
    • Market Size and Forecast, By Vaccine Type, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Vaccine Form, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By End-User, 2016 - 2026 (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Eli Lilly Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • AstraZeneca plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Aventis Pharma Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Indian Immunologicals Limited
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Zydus Cadila
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Panacea Drugs Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
    • Sinovac Biotech Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact